| Dawnelle Jewell, | |
|
299 Edwards St, Youngstown, OH 44502-1504 | |
| (330) 743-1168 | |
| Not Available |
| Full Name | Dawnelle Jewell |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 299 Edwards St, Youngstown, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013380872 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 015542 (Ohio) | Primary |
| Provider Name | Eschman Physical Therapy, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1861469439 PECOS PAC ID: 3779540885 Enrollment ID: O20041210000021 |
News Archive
Even though effective drug cocktails have improved the outlook for many patients with HIV, disease progression, including the time from AIDS onset to death, varies widely from patient to patient.
The U.S. Food & Drug Administration (FDA) has granted Investigational New Drug (IND) regulatory clearance to initiate a Phase I/II clinical trial evaluating Alpha-1 Antitrypsin (AAT) in type 1 diabetics, based on research by Dr. Eli Lewis of Israel's Ben-Gurion University of the Negev.
The New York Times examines an HIV prevention program in China aimed at promoting blood screening that has led "more than 110,000 people" to be tested so far: "On any given night, in 14 cities around the country, hundreds of people flock to makeshift blood collection centers in bars, bathhouses and apartments where workers test for syphilis and HIV, the virus that causes AIDS."
NanoBio has announced that the U.S. Food and Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application for the Phase 1 clinical study of NB-1008, a seasonal influenza vaccine administered via a nasal dropper.
› Verified 8 days ago
| Provider Name | Complete Physical Therapy & Aquatics Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1447037718 PECOS PAC ID: 0345699468 Enrollment ID: O20231213003948 |
News Archive
Even though effective drug cocktails have improved the outlook for many patients with HIV, disease progression, including the time from AIDS onset to death, varies widely from patient to patient.
The U.S. Food & Drug Administration (FDA) has granted Investigational New Drug (IND) regulatory clearance to initiate a Phase I/II clinical trial evaluating Alpha-1 Antitrypsin (AAT) in type 1 diabetics, based on research by Dr. Eli Lewis of Israel's Ben-Gurion University of the Negev.
The New York Times examines an HIV prevention program in China aimed at promoting blood screening that has led "more than 110,000 people" to be tested so far: "On any given night, in 14 cities around the country, hundreds of people flock to makeshift blood collection centers in bars, bathhouses and apartments where workers test for syphilis and HIV, the virus that causes AIDS."
NanoBio has announced that the U.S. Food and Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application for the Phase 1 clinical study of NB-1008, a seasonal influenza vaccine administered via a nasal dropper.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dawnelle Jewell, Po Box 105, Orangeville, OH 44453-0105 Ph: (330) 246-0572 | Dawnelle Jewell, 299 Edwards St, Youngstown, OH 44502-1504 Ph: (330) 743-1168 |
News Archive
Even though effective drug cocktails have improved the outlook for many patients with HIV, disease progression, including the time from AIDS onset to death, varies widely from patient to patient.
The U.S. Food & Drug Administration (FDA) has granted Investigational New Drug (IND) regulatory clearance to initiate a Phase I/II clinical trial evaluating Alpha-1 Antitrypsin (AAT) in type 1 diabetics, based on research by Dr. Eli Lewis of Israel's Ben-Gurion University of the Negev.
The New York Times examines an HIV prevention program in China aimed at promoting blood screening that has led "more than 110,000 people" to be tested so far: "On any given night, in 14 cities around the country, hundreds of people flock to makeshift blood collection centers in bars, bathhouses and apartments where workers test for syphilis and HIV, the virus that causes AIDS."
NanoBio has announced that the U.S. Food and Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application for the Phase 1 clinical study of NB-1008, a seasonal influenza vaccine administered via a nasal dropper.
› Verified 8 days ago
Hannah Lockard, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1325 Churchill Hubbard Rd, Youngstown, OH 44505 Phone: 330-759-5904 Fax: 330-759-8709 | |
Eric Haybarger, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1044 Belmont Ave, Youngstown, OH 44504 Phone: 330-746-7211 | |
Rebekah Michelle Ostrode, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 299 Edwards St, Youngstown, OH 44502 Phone: 330-743-1168 Fax: 330-743-1616 | |
Ernesto Tenedor, LPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1325 Churchill Hubbard Rd, Youngstown, OH 44505 Phone: 330-759-5904 Fax: 330-759-8709 | |
Youngstown Physical Therapists Inc. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 5500 Market St, Suite 127, Youngstown, OH 44512 Phone: 330-783-2256 Fax: 330-783-5068 | |
Nathan Brett Hudzik, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 338 Dehoff Dr, Youngstown, OH 44515 Phone: 330-207-2323 |